There are 3484 resources available
A guide through the new ESMO-MCBS v2.0
Presenter: Nathan Cherny
Session: ESMO-MCBS: 2023 revolution
Resources:
Slides
Webcast
LBA19 - Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
Presenter: Luca Gianni
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
I prefer the combination of anti-PD-1 and anti-LAG-3, and these are the reasons why
Presenter: Reinhard Dummer
Session: First-line therapy in advanced melanoma: What is my preferred choice?
Resources:
Slides
Webcast
Brain metastases: When radiation is (not!) indicated
Presenter: Slavka Lukacova
Session: Neuro-Oncology 101: All you need to know to take care of brain tumour patients
Resources:
Slides
Webcast
Caregivers’ needs along the patient journey: What do oncologists need to know?
Presenter: Bettina Ryll
Session: The importance to address the caregivers’ needs: The perspective of the caregivers
Resources:
Webcast
Modulating TME to overcome primary and acquired resistance
Presenter: Santiago Zelenay
Session: Therapeutic view on tumour immune microenvironment: It's TIME
Resources:
Slides
Webcast
Invited Discussant LBA74 and LBA73
Presenter: Elizabeth Smyth
Session: Proffered Paper session 1 - Gastrointestinal tumours, upper digestive
Resources:
Slides
Webcast
Invited Discussant 1261O and LBA56
Presenter: Jarushka Naidoo
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Data from sequencing trials and new therapeutic targets
Presenter: Cristina Suarez Rodriguez
Session: Optimising overall survival in advanced renal cancer
Resources:
Slides
Webcast
ESMO-Magnitude of Clinical Scale for Haematological Malignancies (ESMO-MCBS:H)
Presenter: Barbara Kiesewetter-Wiederkehr
Session: ESMO-MCBS: 2023 revolution
Resources:
Slides
Webcast